CorMedix Inc.
CRMD
$8.65
$0.111.29%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 384.60% | 617.03% | 1,647.68% | 14,970.67% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 384.60% | 617.03% | 1,647.68% | 14,970.67% | -- |
| Cost of Revenue | 755.14% | 617.50% | 516.22% | 288.84% | 365.78% |
| Gross Profit | 366.66% | 617.00% | 1,863.31% | 22,374.91% | 9,720.23% |
| SG&A Expenses | 100.92% | 63.68% | 44.72% | 14.81% | 33.70% |
| Depreciation & Amortization | 15,328.27% | 13,188.56% | 7,091.91% | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 188.16% | 129.95% | 74.54% | 22.43% | 24.59% |
| Operating Income | 1,308.62% | 817.22% | 303.98% | 184.82% | 126.49% |
| Income Before Tax | 976.94% | 876.28% | 325.13% | 194.81% | 133.27% |
| Income Tax Expenses | 2,002,600.00% | -834.70% | -3,876.59% | 137.37% | 99.99% |
| Earnings from Continuing Operations | 953.61% | 1,009.40% | 452.12% | 196.32% | 134.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 953.61% | 1,009.40% | 452.12% | 196.32% | 134.20% |
| EBIT | 1,308.62% | 817.22% | 303.98% | 184.82% | 126.49% |
| EBITDA | 1,433.19% | 893.29% | 313.13% | 185.95% | 127.35% |
| EPS Basic | 878.35% | 776.93% | 381.60% | 184.18% | 126.09% |
| Normalized Basic EPS | 991.95% | 719.81% | 283.86% | 182.84% | 125.43% |
| EPS Diluted | 870.95% | 700.24% | 354.59% | 180.44% | 123.55% |
| Normalized Diluted EPS | 918.24% | 646.98% | 269.89% | 179.29% | 123.64% |
| Average Basic Shares Outstanding | 24.26% | 22.29% | 16.97% | 10.67% | 12.17% |
| Average Diluted Shares Outstanding | 39.73% | 36.34% | 24.76% | 14.04% | 13.89% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |